A4PBio provide CRO oversight, project management and consultancy services in order to deliver regulatory compliant bioanalysis and bio-logistics solutions to the life science sector. A4PBio offer client-focused solutions in global laboratory selection, through assay development and validation, study sample analysis, data reporting and document review. Combining this with bespoke logistics solutions for the pro-actively managed transport of time and temperature critical biological samples and cell-based therapies. A4PBio's flexible and scalable resources, using considerable Pharmaceutical, Biotechnology and CRO experience, deliver individually built, cost effective, scientifically robust and regulatory compliant outsourcing or consultancy solutions.
As a global life sciences company, Abcam identifies, develops, and distributes high-quality biological reagents and tools that are crucial to research, drug discovery and diagnostics. Working across the industry, the Company supports life scientists to achieve their mission, faster.
Abcam partners with life science organizations to co-create novel binders for use in drug discovery, in vitro diagnostics and therapeutics, driven by the Company’s proprietary discovery platforms and world-leading, antibody expertise.
By constantly innovating its binders and assays, Abcam is helping advance the global understanding of biology and causes of disease, which enables new treatments and improved health. The Company’s pioneering data-sharing approach gives scientists increased confidence in their results by providing validation, user comments and peer-reviewed citations for its 110,000 products.
With twelve sites globally, many of Abcam’s 1,400+ strong team are located in the world’s leading life science research hubs, complementing a global network of services and support.
Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US. Abzena’s complimentary services and technologies in chemistry, biology and manufacturing, are applied to the selection, development and manufacture of better biopharmaceuticals.. . Abzena works with most of the top 20 biopharmaceutical companies and academic groups around the world, and has enabled many of them to progress products (ABZENA inside), through to clinical development. Abzena’s teams at the Babraham Research Campus, Cambridge, UK and in San Diego, CA and Bristol, PA in the US are focused on developing better treatments for patients.
Actigen focuses on the development of novel biotherapeutics, specifically antibodies and protein-based drugs. . . Operating globally from its base in Cambridge, UK, Actigen is working with an expanding network of academic, scientific and medical experts to progress a number of development projects.
Adelphi Healthcare Packaging specialises in the supply of primary packaging to the pharmaceutical and biotechnology industries. Adelphi are agents and distributors for some of the world leading manufacturers of healthcare packaging and holds a comprehensive range of glass, plastic and aluminium containers, high precision dispensing systems, various closures including stoppers, crimp seals and screw caps as well as a range of boxes. Adelphi stocks a number of specialist vials and stoppers that are particularly suited to new product development and that provide a highly inert product contact surface. Our particular speciality is helping companies in the very early stages of development to ensure that primary packaging choices are the most appropriate, both commercially and technically for their products.. www.adelphi-hp.com
Agenda Life Sciences are experts in life science recruitment, contract staffing, research, facility management, and consultancy services. We excel in delivering exceptional life science staffing solutions for both our valued clients and candidates.
Through partnering with Agenda you receive exceptional facility management that acts as the cornerstone for your early-stage Research & Development initiatives. By leveraging our expertise, we not only save you valuable time and resources but also streamline legislative administration.
Our unwavering commitment to the research community is evident in our dedicated services, designed to seamlessly support and enhance research endeavours.
Agenus, Inc. (www.agenusbio.com) is an immuno-oncology company focused on the discovery and development of revolutionary new treatments that engage the body's immune system to benefit cancer patients. By combining multiple powerful platforms, Agenus has established a highly integrated approach for the discovery, development and manufacture of monoclonal antibodies that modulate targets of interest. In addition, Agenus' cancer vaccine programme includes three proprietary platforms focused on individualised and off-the-shelf vaccines uniquely designed for each patient. Agenus' broad portfolio of novel checkpoint and other immuno-modulatory monoclonal antibodies, vaccines and adjuvants work in combination to provide the opportunity to create best-in-class therapeutic regimens.